Frevecitinib is under clinical development by Kinaset Therapeutics and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR ...

Ensifentrine (Ohtuvayre) acts as bronchodilator and non-steroidal anti-inflammatory agent. It is formulated as suspension for inhalational route of administration. Ohtuvayre is indicated for the ...

Those key challenges impacting the care of respiratory diseases include delays in diagnosis due to the intermittent nature of ...

Diabetes Management: Travelling can disrupt routines but careful planning helps keep blood sugar levels in check. Consult ...

The scan method has enabled the team, led by researchers at Newcastle University, UK, to see how air moves in and out of the ...

A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary disease (COPD), and ...

A new lung scanning technique using perfluoropropane visible on MRI scans is set to revolutionize respiratory disease ...